Effect of Safoof-e-Ziabetus in the management of Ziabetus Shakri ( Type 2 Diabetes Mellitus.
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2022/02/040327
- Lead Sponsor
- Central Council of Research in Unani Medicine New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patients of any gender (Male,Female,Transgender)in the age group of 20-70 yrs of age.
Fasting Plasma Glucose levels in the range of 126-150 mg/dl.
Post Prandial Plasma Glucose levels between 200-250 mg/dl.
Patients having ALT,AST,Sr.Creatinine, Blood Urea with normal limits.
Patients ready to participate in the study and willing to follow the instructions.
Patients with Fasting Plasma Glucose level >150 mg/dl
Postprandial Plasma Glucose level >250 mg/dl
-Diabetes Mellitus associated with complications of Ketoacidosis
Diabetes Mellitus Type-I/ Diabetes Insipidus/ Patients on Insulin therapy
Significant Pulmonary/Cardiovascular/Hepato-renal Dysfunction
Pregnant and lactating women
Complications (microangiopathies) associated with longstanding Diabetes like Diabetic Neuropathy, Diabetic Nephropathy and Diabetic Retinopathy
Patients having malignancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Glycemic Control in Type 2 Diabetes MellitusTimepoint: 45 days
- Secondary Outcome Measures
Name Time Method Haematological and biochemical Evaluation of SafetyTimepoint: 45 days